Wellspring Financial Advisors LLC Trims Holdings in Sotera Health Company $SHC

Wellspring Financial Advisors LLC lessened its holdings in shares of Sotera Health Company (NASDAQ:SHC) by 55.9% during the fourth quarter, Holdings Channel reports. The firm owned 64,706 shares of the company’s stock after selling 82,002 shares during the quarter. Wellspring Financial Advisors LLC’s holdings in Sotera Health were worth $1,141,000 at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of the business. Brandes Investment Partners LP increased its holdings in Sotera Health by 23.8% during the 4th quarter. Brandes Investment Partners LP now owns 148,572 shares of the company’s stock valued at $2,621,000 after purchasing an additional 28,577 shares during the period. Focus Partners Advisor Solutions LLC purchased a new position in Sotera Health during the 4th quarter valued at about $194,000. Cerity Partners LLC purchased a new position in Sotera Health during the 4th quarter valued at about $1,800,000. CenterBook Partners LP increased its holdings in Sotera Health by 94.1% during the 4th quarter. CenterBook Partners LP now owns 151,529 shares of the company’s stock valued at $2,673,000 after purchasing an additional 73,473 shares during the period. Finally, JPMorgan Chase & Co. grew its holdings in shares of Sotera Health by 20.3% during the 4th quarter. JPMorgan Chase & Co. now owns 285,691 shares of the company’s stock worth $5,040,000 after acquiring an additional 48,115 shares during the period. Hedge funds and other institutional investors own 91.03% of the company’s stock.

Sotera Health Stock Performance

Sotera Health stock opened at $16.27 on Thursday. The company has a quick ratio of 2.54, a current ratio of 2.82 and a debt-to-equity ratio of 3.56. The company has a market capitalization of $4.64 billion, a P/E ratio of 39.68 and a beta of 1.79. The stock’s 50 day moving average is $15.54 and its 200 day moving average is $16.38. Sotera Health Company has a twelve month low of $10.80 and a twelve month high of $19.85.

Sotera Health (NASDAQ:SHC) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $0.18 earnings per share for the quarter, topping the consensus estimate of $0.17 by $0.01. The company had revenue of $280.05 million for the quarter, compared to the consensus estimate of $270.78 million. Sotera Health had a return on equity of 39.73% and a net margin of 9.91%.The firm’s quarterly revenue was up 10.0% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.14 EPS. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. On average, equities research analysts predict that Sotera Health Company will post 0.86 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on the company. Piper Sandler reiterated an “overweight” rating and set a $22.00 target price (down from $24.00) on shares of Sotera Health in a report on Wednesday, May 6th. Barclays reduced their target price on Sotera Health from $20.00 to $18.00 and set an “overweight” rating on the stock in a report on Tuesday, April 14th. Citigroup upped their target price on Sotera Health from $21.00 to $23.00 and gave the stock a “buy” rating in a report on Tuesday, February 24th. Wall Street Zen downgraded Sotera Health from a “strong-buy” rating to a “buy” rating in a report on Saturday, April 11th. Finally, Weiss Ratings downgraded Sotera Health from a “hold (c)” rating to a “hold (c-)” rating in a report on Thursday, May 21st. Eight investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $20.29.

Insider Buying and Selling at Sotera Health

In related news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of the company’s stock in a transaction that occurred on Wednesday, May 13th. The stock was sold at an average price of $15.17, for a total value of $193,194,516.17. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. 15.36% of the stock is owned by insiders.

Sotera Health Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.